Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Corcept Therapeutics Inc (NASDAQ: CORT) closed at $22.66 in the last session, down -1.48% from day before closing price of $23.00. In other words, the price has decreased by -$1.48 from its previous closing price. On the day, 0.97 million shares were traded. CORT stock price reached its highest trading level at $23.44 during the session, while it also had its lowest trading level at $22.57.
Ratios:
We take a closer look at CORT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.37 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.49. For the most recent quarter (mrq), Quick Ratio is recorded 4.31 and its Current Ratio is at 4.39. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 06, 2023, Upgraded its rating to Buy and sets its target price to $38 from $29 previously.
On April 11, 2023, SVB Securities started tracking the stock assigning a Market Perform rating and target price of $25.
On April 04, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on April 04, 2023, with a $27 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 04 ’24 when Lyon Joseph Douglas sold 5,443 shares for $26.00 per share. The transaction valued at 141,524 led to the insider holds 7,314 shares of the business.
Swisher Daniel N JR sold 2,200 shares of CORT for $55,660 on Apr 01 ’24. The Director now owns 0 shares after completing the transaction at $25.30 per share. On Apr 01 ’24, another insider, Lyon Joseph Douglas, who serves as the insider of the company, sold 500 shares for $26.01 each. As a result, the insider received 13,004 and left with 7,314 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORT now has a Market Capitalization of 2352946432 and an Enterprise Value of 1977634048. As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.90, and their Forward P/E ratio for the next fiscal year is 17.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.86 while its Price-to-Book (P/B) ratio in mrq is 4.62. Its current Enterprise Value per Revenue stands at 4.1 whereas that against EBITDA is 18.257.
Stock Price History:
Over the past 52 weeks, CORT has reached a high of $34.28, while it has fallen to a 52-week low of $20.87. The 50-Day Moving Average of the stock is -4.99%, while the 200-Day Moving Average is calculated to be -14.68%.
Shares Statistics:
According to the various share statistics, CORT traded on average about 1.29M shares per day over the past 3-months and 771350 shares per day over the past 10 days. A total of 103.41M shares are outstanding, with a floating share count of 89.26M. Insiders hold about 13.77% of the company’s shares, while institutions hold 80.37% stake in the company. Shares short for CORT as of 1711584000 were 21330479 with a Short Ratio of 16.59, compared to 1709164800 on 19857582. Therefore, it implies a Short% of Shares Outstanding of 21330479 and a Short% of Float of 33.110002.
Earnings Estimates
Its stock is currently analyzed by Costco Wholesale Corporation different market analysts. The consensus estimate for the next quarter is $53.96, with high estimates of $53.20 and low estimates of $237.30.
Analysts are recommending an EPS of between $Industrials and $Healthcare for the fiscal current year, implying an average EPS of $Basic Materials.
